Navigation Links
Muscle wasting disease treatable using stem cell therapy

A medical research team looking for a cure for Duchenne Muscular Dystrophy, an extremely debilitating disorder which causes wasting of muscles, submitted their findings// recently.

The Stem cell Studies done by the team of Italian researchers seem to offer hope for those who suffer from the disease.

Duchenne muscular dystrophy is a severe progressive disease of genetic origin that results in muscle wasting which usually begins in the lower limbs. It is seen to affect young boys more often and starts showing up when a child is about 3-5 years old and gradually by the age of twelve patients who suffer from this illness find themselves unable to walk without support.

Other than drugs that slow down the muscle wasting and those that control seizures no medicines have been proven so far that could cure the illness completely. The stem cell therapy done by Italian scientists on a group of dogs with muscular dystrophy has shown remarkably positive results.

Professor Giulio Cossu, from the San Raffaele Scientific Institute in Milan and his team of researchers introduced stem cells into the blood stream of golden retrievers that were suffering from muscular wasting. The stem cells used for therapy were taken from adult dogs and not from embryos. Amazingly the dogs responded well to the treatment.

The scientists have expressed hope that the results of their study could revolutionize the possibilities of a successful cure for Duchenne Muscular Dystrophy in humans as well.

The organization, Muscular Dystrophy Association helped to fund the studies and research work.

Page: 1

Related medicine news :

1. Protein said to Improve Muscle Loss
2. ‘Protein’ Produced By Overstressed Heart Muscle a Strong Indicator Of Heart Diseae
3. Protein Found To Improve Muscle Loss
4. Strong Pelvic Muscles Found To Facilitate Childbirth
5. Loss Of Dystrophin: Common Thread In Cancer And MS Muscle Wasting
6. Scientists identify Genes Needed For Muscle Development
7. Muscle Derived Stem Cell Can Repair Damaged Cartilage
8. $ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle.
9. Stem Cell Therapy Regenerates Heart Muscle In Heart Attack Patients
10. Expect Aching Muscles And Joints This Sports Season
11. Acetaminophen does not Protect Heart Muscle
Post Your Comments:

(Date:12/1/2015)... ... 2015 , ... Speech and physical therapies are traditionally conducted ... and under the right circumstances, these practices can be merged. This combination ... his or her therapeutic sessions, as well as gives the physical and speech ...
(Date:12/1/2015)... ... December 01, 2015 , ... It’s official: Tattoo taboo is a ... number even greater among Millennials (a whopping one in three aged 18 to 25 ... who are dissatisfied with their ink. In fact, RealSelf , the world’s largest ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... everything. That is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch ... product in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President ...
(Date:12/1/2015)... Burlington, MA (PRWEB) , ... December 01, 2015 , ... ... the release of Clarity, the latest addition to the devices for sale in the ... technologies, 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: Grit , ... control over customization, the possibilities are truly endless, all with a click of a ... position, vertical flip, horizontal flip, depth of field and more, all within Final Cut ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015 Building on its ... & Johnson (NYSE: JNJ ) today announced ... Companies to significantly reduce the burden of HIV ... 74 percent of new HIV infections among adolescents ... AIDS Day, these new initiatives include collaborations with ...
(Date:12/1/2015)... 2015 ) ... Equipment and Disposables Market by product, by Animal ... their offering. --> ) has ... and Disposables Market by product, by Animal - ... offering. --> Research and Markets ( ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: